← FDA Drug Approvals (Drugs@FDA)

CLINDAMYCIN PHOSPHATE AND TRETINOIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOLARIS PHARMA CORP · Approved 2022-02-10

Drug application

FDA Application #
ANDA212845
Application type
Abbreviated New Drug Application (Generic)
Brand name
CLINDAMYCIN PHOSPHATE AND TRETINOIN
Generic name
CLINDAMYCIN PHOSPHATE AND TRETINOIN
Active ingredients
CLINDAMYCIN PHOSPHATE; TRETINOIN
Dosage form
GEL
Route
TOPICAL
Marketing status
Prescription
Sponsor
SOLARIS PHARMA CORP
Manufacturer
Solaris Pharma Corporation
First approval
2022-02-10

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown